AU1595101A - Oncolytic combinations for the treatment of cancer - Google Patents

Oncolytic combinations for the treatment of cancer

Info

Publication number
AU1595101A
AU1595101A AU15951/01A AU1595101A AU1595101A AU 1595101 A AU1595101 A AU 1595101A AU 15951/01 A AU15951/01 A AU 15951/01A AU 1595101 A AU1595101 A AU 1595101A AU 1595101 A AU1595101 A AU 1595101A
Authority
AU
Australia
Prior art keywords
cancer
treatment
oncolytic
combinations
oncolytic combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15951/01A
Inventor
Roger Stuart Benjamin
Jason Scott Sawyer
Beverly Ann Teicher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU1595101A publication Critical patent/AU1595101A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU15951/01A 1999-11-11 2000-11-09 Oncolytic combinations for the treatment of cancer Abandoned AU1595101A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16471699P 1999-11-11 1999-11-11
US60164716 1999-11-11
PCT/US2000/030894 WO2001034134A2 (en) 1999-11-11 2000-11-09 Oncolytic combinations for the treatment of cancer

Publications (1)

Publication Number Publication Date
AU1595101A true AU1595101A (en) 2001-06-06

Family

ID=22595775

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15951/01A Abandoned AU1595101A (en) 1999-11-11 2000-11-09 Oncolytic combinations for the treatment of cancer

Country Status (2)

Country Link
AU (1) AU1595101A (en)
WO (1) WO2001034134A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1916601A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
DE10323279A1 (en) * 2003-05-21 2004-12-16 Stada Arzneimittel Ag Ready-to-use gemcitabine solutions
DE10359828A1 (en) * 2003-12-12 2005-07-28 Zoser B. Dr.Rer.Nat. Salama CHP gemcitabine combination agents and their use as antitumor agents, in particular anti-metastatic agents
EP2172222A3 (en) 2004-04-26 2010-06-23 Ono Pharmaceutical Co., Ltd. Novel BLT2-mediated disease, BLT2-binding agent and compound
GB0410103D0 (en) * 2004-05-06 2004-06-09 Biolipox Ab New method
WO2019109147A1 (en) * 2017-12-06 2019-06-13 Omara Stephen Kenneth Methods of treating cancer with leukotriene receptor antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation

Also Published As

Publication number Publication date
WO2001034134A3 (en) 2002-02-14
WO2001034134A2 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
AU2020501A (en) Chemotherapy treatment
AU1958897A (en) Egf-genistein conjugates for the treatment of cancer
AU2495200A (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU3791601A (en) Treatment of coal
EP1176964B8 (en) Uses of et743 for treating cancer
IL148579A0 (en) Oncolytic combinations for the treatment of cancer
AU5089400A (en) Arthritis treatment
AU2000258650A1 (en) 2-piperidone compounds for the treatment of cancer
AU6062900A (en) Substituted indole compounds and their use for the treatment of cancer
AU1916601A (en) Oncolytic combinations for the treatment of cancer
AU1916501A (en) Oncolytic combinations for the treatment of cancer
AU5547000A (en) Novel treatment
AU1595001A (en) Oncolytic combinations for the treatment of cancer
AU1917101A (en) Oncolytic combinations for the treatment of cancer
AU4556800A (en) Novel treatment
AU7636800A (en) Improved ricin-like toxins for treatment of cancer
AU1595101A (en) Oncolytic combinations for the treatment of cancer
AUPQ367699A0 (en) Treatment of cancer
AU5552400A (en) Treatment of cancer
AU2001257325A1 (en) Cancer treatment
AU1592901A (en) Oncolytic combinations for the treatment of cancer
AU1618901A (en) Treatment of rosacea

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase